| CRISPR screen in regulatory T cells reveals modulators of Foxp3 JT Cortez, E Montauti, E Shifrut, J Gatchalian, Y Zhang, O Shaked, Y Xu, ... Nature 582 (7812), 416-420, 2020 | 160 | 2020 |
| Host miR-155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism S Chen, L Wang, J Fan, C Ye, D Dominguez, Y Zhang, TJ Curiel, D Fang, ... Cancer research, canres. 2331.2014, 2014 | 103 | 2014 |
| Exogenous IL-33 restores dendritic cell activation and maturation in established cancer D Dominguez, C Ye, Z Geng, S Chen, J Fan, L Qin, A Long, L Wang, ... The Journal of Immunology 198 (3), 1365-1375, 2017 | 101 | 2017 |
| CD73: an emerging checkpoint for cancer immunotherapy S Chen, DA Wainwright, JD Wu, Y Wan, DE Matei, Y Zhang, B Zhang Immunotherapy 11 (11), 983-997, 2019 | 87 | 2019 |
| CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy S Chen, J Fan, M Zhang, L Qin, D Dominguez, A Long, G Wang, R Ma, ... Nature communications 10 (1), 150, 2019 | 82 | 2019 |
| Type 2 innate lymphoid cells impede IL-33–mediated tumor suppression A Long, D Dominguez, L Qin, S Chen, J Fan, M Zhang, D Fang, Y Zhang, ... The Journal of Immunology 201 (11), 3456-3464, 2018 | 71 | 2018 |
| Targeting ornithine decarboxylase by α-difluoromethylornithine inhibits tumor growth by impairing myeloid-derived suppressor cells C Ye, Z Geng, D Dominguez, S Chen, J Fan, L Qin, A Long, Y Zhang, ... The Journal of Immunology 196 (2), 915-923, 2016 | 68 | 2016 |
| Graft-versus-host disease is enhanced by selective CD73 blockade in mice L Wang, J Fan, S Chen, Y Zhang, TJ Curiel, B Zhang PLoS One 8 (3), e58397, 2013 | 58 | 2013 |
| Cutting edge: microRNA-223 regulates myeloid dendritic cell–driven Th17 responses in experimental autoimmune encephalomyelitis I Ifergan*, S Chen*, B Zhang, SD Miller (*Co-first authors) The Journal of Immunology 196 (4), 1455-1459, 2016 | 57 | 2016 |
| Exogenous IL-33 overcomes T cell tolerance in murine acute myeloid leukemia L Qin, D Dominguez, S Chen, J Fan, A Long, M Zhang, D Fang, Y Zhang, ... Oncotarget 7 (38), 61069, 2016 | 56 | 2016 |
| The Expression of Adenosine A2B Receptor on Antigen-Presenting Cells Suppresses CD8+ T-cell Responses and Promotes Tumor Growth S Chen, I Akdemir, J Fan, J Linden, B Zhang, C Cekic Cancer immunology research 8 (8), 1064-1074, 2020 | 51 | 2020 |
| Regulating tumor myeloid-derived suppressor cells by microRNAs S Chen, Y Zhang, TM Kuzel, B Zhang Cancer cell & microenvironment 2 (1), 2015 | 50 | 2015 |
| WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability Corrigendum in/10.3892/ol. 2018.8757 M Zhang, D Dominguez, S Chen, J Fan, L Qin, A Long, X Li, Y Zhang, ... Oncology letters 14 (3), 3580-3586, 2017 | 37 | 2017 |
| Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer S Chen, P Xie, M Cowan, H Huang, H Cardenas, R Keathley, EJ Tanner, ... The Journal of Clinical Investigation 132 (14), 2022 | 36 | 2022 |
| Development of spherical nucleic acids for prostate cancer immunotherapy L Qin, S Wang, D Dominguez, A Long, S Chen, J Fan, J Ahn, K Skakuj, ... Frontiers in immunology 11, 1333, 2020 | 23 | 2020 |
| Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer LE Sima*, S Chen*, H Cardenas*, G Zhao, Y Wang, C Ivan, H Huang, ... Journal for ImmunoTherapy of Cancer 9 (9), e002682, 2021 | 13 | 2021 |
| Comprehensive T‐cell immunophenotyping and next‐generation sequencing of human papillomavirus (HPV)‐positive and HPV‐negative head and neck squamous cell carcinomas K Poropatich, J Fontanarosa, S Swaminathan, D Dittmann, S Chen, ... The Journal of Pathology 243 (3), 354-365, 2017 | 13 | 2017 |
| Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium EL Barber*, S Chen*, MJ Pineda, SE Robertson, EK Hill, D Teoh, ... Cancer research communications 2 (10), 1293-1303, 2022 | 6 | 2022 |
| Phase II trial of guadecitabine priming and pembrolizumab in platinum resistant recurrent ovarian cancer. D Matei, A Pant, JW Moroney, GF Fleming, E Tanner, WM Swetzig, J Xu, ... Journal of Clinical Oncology 38 (15_suppl), 6025-6025, 2020 | 6 | 2020 |
| Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity Z Fu*, S Chen*, Y Zhu, D Zhang, P Xie, Q Jiao, J Chi, S Xu, Y Xue, X Lu, ... Science Advances 9 (1), eadd6626, 2023 | 4 | 2023 |
